Complete preoperative physical exam, anesthesia clearance, coagulation profile assessment, and 8-hour nil-per-os (NPO) status. The recipient site must be assessed for infection and vascularity, and donor site selection must be determined. Antibiotic prophylaxis is administered within 60 minutes of the incision. Ensure signed informed consent and baseline wound documentation.
The graft site must remain immobilized for 3-5 days to promote adherence. Monitor for hematoma, seroma, or graft site infection. The donor site is dressed with a non-adherent dressing and managed for pain. Physical therapy consultation for mobilization, wound care education for the patient, and assessment for graft take success prior to discharge. Standard hospital length of stay is required for monitoring.
Comprehensive Clinical Guide: Split Thickness Skin Graft (STSG)
1. Introduction and Overview
A Split Thickness Skin Graft (STSG) is a definitive surgical procedure utilized in reconstructive and plastic surgery to achieve wound closure. It involves the harvesting of the epidermis and a portion of the dermis from a healthy donor site and transferring it to a recipient site (the wound bed).
Unlike Full-Thickness Skin Grafts (FTSG), which include the entire dermis, an STSG allows the donor site to re-epithelialize spontaneously from the remaining adnexal structures (hair follicles, sweat glands, and sebaceous glands) located in the deep dermis. This makes STSG the gold standard for covering large surface area defects, such as extensive burns, chronic ulcers, or post-traumatic soft tissue losses where local tissue rearrangement or flap coverage is impractical.
2. Technical Specifications and Mechanisms of Graft Take
The success of an STSG relies on the biological process of "graft take," which occurs in three distinct, overlapping phases:
The Three Phases of Graft Integration
| Phase | Duration | Mechanism |
|---|---|---|
| Plasmatic Imbibition | 24–48 hours | The graft absorbs nutrients via capillary action from the wound bed fibrin network. The graft appears edematous. |
| Inosculation | 48–72 hours | Donor and recipient vessels align. Endothelial buds from the wound bed connect with the graft’s pre-existing vascular plexus. |
| Neovascularization | 72+ hours | New blood vessels infiltrate the graft (angiogenesis). The graft regains pink coloration and sensory innervation begins. |
Classification of Thickness:
* Thin (0.005–0.010 inches): High take rate, but significant contraction and poor cosmetic appearance.
* Intermediate (0.011–0.018 inches): Standard clinical use; balances durability with graft take success.
* Thick (0.019–0.025 inches): Minimal contraction and better durability, but requires a highly vascularized wound bed for survival.
3. Clinical Indications and Usage
STSG is indicated when primary closure is impossible or when secondary intention healing would result in unacceptable scarring or prolonged morbidity.
- Thermal/Chemical Burns: The primary indication for large-surface area coverage.
- Chronic Wounds: Venous stasis ulcers, pressure injuries (Stage IV), and diabetic foot ulcers that have failed conservative management.
- Traumatic Defects: Avulsion injuries, degloving injuries, and complex orthopedic wounds with exposed bone (provided the periosteum is intact).
- Post-Excision Reconstruction: Following the resection of malignant tumors (e.g., Basal Cell Carcinoma, Squamous Cell Carcinoma) where flap reconstruction is not feasible.
- Infected Wounds: Only after the wound bed has been debrided and demonstrates healthy, granulating tissue (pink, beefy, non-purulent).
4. Patient Pre-Operative Preparation
Success is predicated on a clean, well-vascularized "wound bed."
- Nutritional Optimization: Serum albumin/pre-albumin levels should be optimized. Protein supplementation is critical for collagen synthesis.
- Wound Bed Preparation: Serial debridement to remove necrotic tissue, slough, and biofilm. Negative Pressure Wound Therapy (NPWT) is often used for 3–5 days pre-op to promote granulation tissue.
- Vascular Assessment: For lower extremity grafts, ensure arterial inflow (ABI > 0.5) is sufficient to support the graft.
- Medical Clearance: Smoking cessation is mandatory for at least 2–4 weeks pre- and post-operatively, as nicotine induces profound vasoconstriction, leading to graft ischemia.
5. The Procedure: Step-by-Step
Step 1: Donor Site Preparation
Common donor sites include the thigh, buttocks, or back. The area is cleaned with antiseptic (e.g., Chlorhexidine) and lubricated with mineral oil or saline to allow the dermatome to glide smoothly.
Step 2: Harvesting
A calibrated dermatome (manual or powered) is used to harvest the skin. The surgeon maintains constant tension on the skin to ensure a uniform thickness.
Step 3: Meshing (Optional)
The graft is often passed through a meshing device. This creates a diamond-patterned expansion, which:
* Allows the graft to cover a larger surface area.
* Allows for the egress of serum/blood (preventing hematoma formation, the leading cause of graft failure).
Step 4: Fixation
The graft is applied to the recipient site and secured using:
* Sutures (Monofilament): For precise edge approximation.
* Staples: For speed and stability on larger areas.
* Fibrin Glue: Increasingly used for fixation in sensitive areas to prevent shear.
Step 5: Bolster Dressing
A tie-over bolster (usually Xeroform, moist cotton balls, and non-adherent gauze) is sutured over the graft to maintain firm, uniform contact with the wound bed and prevent shearing forces.
6. Post-Operative Recovery and Complications
Recovery Protocol
- Immobilization: The grafted area must be immobilized for 3–5 days to prevent shear.
- Monitoring: The bolster is typically removed at day 5. The graft is inspected for necrosis, hematoma, or infection.
- Compression: Once healed, the graft site should be managed with silicone sheeting or pressure garments for 6–12 months to minimize hypertrophic scarring.
Potential Complications
| Complication | Cause | Management |
|---|---|---|
| Hematoma/Seroma | Inadequate drainage/pressure | Evacuation via needle aspiration or surgical re-opening. |
| Graft Infection | Bacterial colonization | Topical antimicrobials, systemic antibiotics, or wet-to-dry dressing changes. |
| Shear/Movement | Inadequate immobilization | Strict limb elevation and splinting. |
| Hypertrophic Scarring | Genetic predisposition/tension | Intralesional corticosteroids, pressure therapy. |
7. Alternative Treatments
- Full-Thickness Skin Graft (FTSG): Better cosmetic outcomes and less contraction; requires a smaller, well-vascularized bed.
- Dermal Substitutes: (e.g., Integra, Dermagraft) Used to provide a dermal scaffold prior to STSG application.
- Local/Free Flaps: Used when the wound bed has poor vascularity (e.g., exposed tendon or bone without periosteum).
- Secondary Intention: Letting the wound heal on its own; usually only for small, shallow defects.
8. Frequently Asked Questions (FAQ)
Q1: How long does an STSG take to heal?
A: The donor site typically heals within 10–14 days. The recipient site requires 5–7 days for initial graft take and several months for full maturation of the tissue.
Q2: Will the graft grow with the patient?
A: No. Unlike local flaps, STSGs do not grow. If performed on a pediatric patient, the graft may require revision as the child grows.
Q3: What is the most common reason for graft failure?
A: Hematoma formation. If blood collects beneath the graft, it separates the graft from the wound bed, preventing the diffusion of nutrients and oxygen.
Q4: Can I exercise after the surgery?
A: No. Activity must be restricted for at least 2–3 weeks to ensure the graft adheres properly and to prevent mechanical shear.
Q5: Is an STSG permanent?
A: Yes, once the graft has integrated (taken), it becomes a permanent part of the skin, though it may be thinner and have less sensation than original skin.
Q6: Why is the donor site so painful?
A: The donor site is essentially a partial-thickness burn. It exposes nerve endings, which are highly sensitive. Pain management is a critical component of post-op care.
Q7: Will I have a scar?
A: Yes. Both the donor and recipient sites will scar. The donor site will look like a large scrape/burn, and the recipient site will have a distinct texture and color mismatch compared to surrounding skin.
Q8: Can an STSG be used on an infected wound?
A: Generally, no. A graft placed on an infected wound will fail due to bacterial enzymes breaking down the graft-bed interface. The infection must be treated first.
Q9: What is "meshing" and why is it done?
A: Meshing increases the surface area of the skin graft. It allows the surgeon to cover a large wound with a small amount of harvested skin and provides drainage channels for blood and fluid.
Q10: Are there sensory changes in the graft?
A: Yes. While some sensation returns over months to years as nerves regenerate, the graft will never have the same sensory acuity as the original skin.
9. Conclusion
Split Thickness Skin Grafting remains a cornerstone of modern reconstructive surgery. By understanding the physiological requirements of graft take and adhering to meticulous surgical technique and post-operative immobilization, surgeons can achieve functional and aesthetic closure of complex wounds. Success is not merely defined by the procedure itself, but by the rigorous management of the wound bed, the patient’s nutritional status, and the prevention of shearing forces during the critical early recovery phase. As clinical technology evolves, the integration of advanced dermal substitutes with STSG continues to expand the horizons of what can be successfully reconstructed in the trauma and chronic wound patient populations.